Abeona Therapeutics Inc (NAS:ABEO)
$ 4.2 -0.25 (-5.62%) Market Cap: 171.56 Mil Enterprise Value: 124.74 Mil PE Ratio: 0 PB Ratio: 7.51 GF Score: 45/100

Q4 2020 Abeona Therapeutics Inc Earnings Call Transcript

Mar 25, 2021 / 12:30PM GMT
Release Date Price: $47 (+5.62%)
Operator

Good day, and welcome to the Abeona Therapeutics Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions) As a reminder, today's conference call is being recorded.

I'll now introduce you to today's conference host, Greg gin, Vice President of Investor Relations and Corporate Communications at Abeona. Please go ahead.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR & Corporate Communications

Thank you, Holly. Good morning, everyone. I would like to welcome you, and thank you for joining us on our fourth quarter and full year 2020 conference call. Yesterday, after the close of financial markets, we issued a press release announcing the fourth quarter and full year results and recent operational progress. The press release is posted on our website at www.abeonatherapeutics.com.

On the call today with prepared remarks are Michael Amoroso, Chief Executive Officer of Abeona; and Ed Carr, Chief Accounting Officer. After the prepared remarks, we will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot